ArticleMedicina (Kaunas, Lithuania)2025

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing-Remitting Multiple Sclerosis.

Paulius Sėdžius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.